Starting up a company in Life Sciences? Aiming to commercialise your research?
Take part in Health~Holland Venture Challenge!
The Health~Holland Venture Challenge is part of the LifeSciences@Work support programme. A dedicated team offer their expertise to life sciences researchers to translate inventions into viable business ideas.
In two 3-day workshops ‘competing’ teams will be challenged to write business plans, to learn how to pitch business cases and more valuable coaching. At the end of the Challenge, the team with the best Venture Plan and pitch is awarded a moneyprize.
How it works: The Venture Challenge Programme further explained.
Edition Spring 2015: call closed.
Edition Fall 2015: stay tuned.
Interested in previous Venture Challenges?
Editions 2008 untill 2014: see: www.venturechallenge.nl
Meet the Health~Holland Venture Challenge Spring 2015 teams!
Breathcloud: Providing on-the-spot diagnostic tools to determine patient specific treatment plans for obstructive lung disease.
Conquest: Revolutionizes all clinical imaging modalities with a versatile contrast agent, based on a patented nanoparticle.
CysTmx: Prevents metastasis hence turning cancer into a chronic disease.
Micellas: Offering a delivery platform with superior therapeutics, flow chemistry proof. Targeted hydrophobic drugs become reality.
PharmTox: Delivering transporter assays to prevent failures in drug-drug interactions during drug development.
Sequenomics: Informed decision making in drug development by combining HT sequence data with in silico protein folding information.
What startups want (from their accelerators): support, support and support – and maybe a bit of cash?
Read the findings of a study by Tech.eu what startups say about their accelerator experience.
Great news for NightBalance: The Sleep Position Trainer is reimbursed in the Netherlands!
NightBalance proudly announces to receive coverage from Achmeathe for the innovative Sleep Position Trainer, which prevents obstructive sleep apnea . NightBalance is the winning team of the Venture Challenge Fall 2010.
LS@W partner BioGeneration Ventures sells its portfolio company Lanthio Pharma BV to MorphoSys AG.
BioGeneration co-founded Lanthio Pharma in 2011 and provided its initial seed funding.
Dutch Life Science SME event
Including the Venture Challenge Spring 2015 finals.
Invitation! Become a partner of LS@W.
Help life sciences researchers to take their invention from the lab to the market.
Introducing Health~Holland Value Centre.
Aiming to facilitate entrepreneurship with sector specific knowledge.
Kite Pharma (USA) acquired former Venture Challenge participant T-Cell Factory
T-Cell Factory has the ability to discover and develop tumor-specific TCRs for broad application in cancer treatment. T-Cell has been renamed Kite Pharma EU.